Opportunities and Challenges in the Cannabis Industry 

Once an illegal and somewhat niche product, legal cannabis is now a fast-growing global industry impacting everything from pharmaceuticals, to beauty products, to packaging, to local banking. Hemp, a variety of the cannabis plant is even finding its way into clothing and construction products.

According to BDS and Arcview Market Research, it’s estimated that global consumer spending on cannabis will reach $32B by 2022. That’s 3 times the current spending level.

Medical marijuana is already legal across most of the US, and 10 states (plus Washington DC) have legalized marijuana for recreational use. As of October 2018, it is now  fully legal in all of Canada  as well. The 2018 Farm Bill legalized hemp in the US, opening the door to a wealth of market opportunities.

In this webinar, guest speaker David Traylor, Sr. Managing Director at Golden Eagle Partners, brings 15 years of biotech operational experience combined with 6 years of experience in the cannabis industry. David is uniquely qualified to advise on today’s fast-growing cannabis sector and provide the implications for a broad span of industries and its investors.

During the webinar, you’ll learn :

  • How the cannabis sector got to where it is today

  • Major events that have helped build the industry

  • The differences between marijuana and hemp

  • Current challenges to the MJ and hemp industries

  • What potential involvement the FDA may have

  • What the future holds for MJ and hemp

  • Opportunities and risks for investors

  • And much more...

watch THE


ShareVault’s secure document sharing solution gives organizations of all sizes in all industries the confidence to simply and securely share sensitive documents with third parties during due diligence, fundraising, board communications, and any circumstance when it is crucial that confidential information is maintained under the highest level of security and control.

Compared to consumer-grade solutions, ShareVault virtual data rooms offer many features that give you control and document intelligence with the highest level of document-protection and monitoring available. Learn more.

our partner:

Company team

David Traylor

Sr. Managing Director, Golden Eagle Partners

David Traylor is Senior Managing Director at Golden Eagle Partners, a firm he founded in 2012 to advise life science companies. After advising on various transactions in the life science sector, he took an interest in the cannabis sector and started advising cannabis companies in 2013. In 2014, he joined Surna, Inc. (OTC:SRNA) as Chief Business Officer. After close to a year stint at Surna, Mr. Traylor re-founded Golden Eagle Partners to provide his knowledge to companies across the cannabis sector. Before Golden Eagle Partners, Mr. Traylor served at leading investment banking firms including Pacific Growth Equities (which later became Wedbush), Caris & Company and Headwaters MB (which later became Capstone Headwaters). During his banking tenures he has advised private and public biotechnology and medical device companies in various transactions including IPOs, private offerings, mergers and acquisitions totaling over $500 million in value.

Before investment banking, Mr. Traylor spent fifteen years in diverse operational roles in biotechnology companies, from research and development to business development, manufacturing, program management and senior management. He began his career in biotechnology, with a position in bioprocess manufacturing at Synergen (acquired by Amgen), and then moved into R&D and process development positions at Somatogen, a company pursuing a recombinant blood substitute. After Somatogen (acquired by Baxter), he led the management of programs and development initiatives at Affymetrix (acquired by Thermo Fisher), the leading innovator in microarray technology. Mr. Traylor began his business development career at Deltagen then moved over the lead the U.S. operations for atugen AG (acquired by Silence Therapeutics), a Berlin-based functional genomics company. At Bioseek (acquired by Asterand), David led the business development efforts for one of the first systems biology companies.In 1988, Mr. Traylor was one of five Colorado players selected to play for the Denver Rifles in the American Lacrosse League (ALL) – the first U.S. professional field lacrosse league. Mr. Traylor is parlaying his athletic background and knowledge in cannabis as a valuable member of Athletes for Care. He received B.A. degrees from the University of Colorado, Boulder in Biochemistry and Molecular, Cellular and Developmental Biology and an M.B.A. from the Leeds School of Business at the University of Colorado-Boulder. He is also the inventor on three issued U.S. patents. Mr. Traylor is a registered representative and has passed the FINRA Series 7, 63 and 66 examinations. Learn more.